MYB alterations are also highly prevalent in angiocentric gliomas, reinforcing their role in glioma subtyping.149 Future research will likely focus on MYB- and MYBL1-driven oncogenic mechanisms, particularly in pediatric LGGs, to refine diagnostic classification and identify targeted therapeutic strategies. This evidence concerns the gene MYBL1 and glioma.